Genfit Stock

Genfit EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Genfit (GNFT.PA) as of Aug 4, 2026 is 28.75. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -7.44 — a change of -486.40% (higher).

EV/FCF

28.75

YoY

-486.40%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Genfit is 2026 28.75 . EV/FCF (Enterprise Value to Free Cash Flow) of Genfit was 2025 -7.44 . It decreases by -486.40% higher compared to the previous year.
Access this data via the Eulerpool API

Genfit Stock analysis

What does Genfit do? Genfit SA is a French company specializing in the development of therapies for the treatment of liver diseases, specifically non-alcoholic steatohepatitis (NASH). The company was founded in 1999 and is headquartered in Loos, France. Genfit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genfit stock

EV/FCF (Enterprise Value to Free Cash Flow) of Genfit is 28.75 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Genfit changed from -7.44 to 28.75, representing a -486.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Genfit since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Genfit with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Genfit

All Key Metrics — Genfit